Pemphigus Vulgaris Market
Pemphigus Vulgaris Market
Pemphigus Vulgaris (PV) is a rare autoimmune blistering disease caused by desmoglein-targeting autoantibodies. Management focuses on lowering autoantibody levels through immunosuppression. Standard treatments include corticosteroids, anti-CD20 antibodies (rituximab, ofatumumab), and steroid-sparing agents like azathioprine, mycophenolate mofetil, or cyclophosphamide.
Download the full infographic to uncover detailed insights: https://www.delveinsight.com/infographics/pemphigus-vulgaris-market?utm_source=infographics&utm_medium=promotion&utm_campaign=akpr
